Financials
Financial year 2025
APOTHEEK TENNSTEDT-LEVIE from Overijse, company number BE0426500981, closed financial year 2025 with a result of € 217,491 after tax. For that financial year APOTHEEK TENNSTEDT-LEVIE recorded a gross margin of € 656,509 and equity of € 408,755. Compared with financial year 2024, the result moved from € 221,437 to € 217,491. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.
€ 408,755
▲ 7% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 217,491
▼ 2% vs 2024
Profit after tax over the fiscal year.
€ 338,697
▼ 7% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 190,000 paid out
87 % of the profit went to the shareholders, mostly to VALAPHARMA (100 % of the shares). That is where the money ends up.
People and assets in 2025
5.9
▲ 0.5 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 366,178
€ 62,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 7,485
▼ 22% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 70,909
▼ 8% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 61,921
▲ 2% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 592,617 | € 534,819 | € 656,459 | € 656,509 | |
| Profit after taxes | € 209,341 | € 142,462 | € 221,437 | € 217,491 | ▼ 2% |
| Equity | € 757,366 | € 499,828 | € 381,264 | € 408,755 | ▲ 7% |
| Total debts | € 289,993 | € 595,928 | € 543,241 | € 547,741 | ▲ 1% |
| Cash | € 535,154 | € 537,876 | € 362,926 | € 338,697 | ▼ 7% |
| Retained profit | € 748,682 | € 491,144 | € 372,580 | € 400,071 | ▲ 7% |
| Dividend | € 140,000 | € 400,000 | € 340,000 | € 190,000 | ▼ 44% |
| Balance sheet total | € 1,047,359 | € 1,095,755 | € 924,505 | € 956,496 | ▲ 3% |
| Employees (FTE) | 5.1 | 4.5 | 5.4 | 5.9 | ▲ 0.5 |
Key figures of APOTHEEK TENNSTEDT-LEVIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to APOTHEEK TENNSTEDT-LEVIE?
What happened at APOTHEEK TENNSTEDT-LEVIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 217,491 (▼ 2% vs 2024). Source: NBB ↗
- Valapharma BV became a director. NBB
- New establishment in Overijse. KBO
- Start of the company according to the CBE. KBO
In short
From € 209,341 profit in 2022 to € 217,491 profit in 2025.
Paid € 249,349 in corporate taxes since 2022.
Best year ever: 2024, with € 221,437 profit.
On average € 111,300 of value added per employee in 2025.
A new publication or filing at APOTHEEK TENNSTEDT-LEVIE? We notify you, reason included.
Follow APOTHEEK TENNSTEDT-LEVIEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of VALAPHARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
APOTHEEK TENNSTEDT-LEVIEBehind APOTHEEK TENNSTEDT-LEVIE is Valapharma BV. The shares are held by VALAPHARMA (99.9%).
Directors
According to the 2025 annual accounts
since 2023
Shareholders
99.9%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Brusselsesteenweg 390
3090 Overijse
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0426.500.981
- VAT number
- BE 0426.500.981
- Registered office
- Brusselsesteenweg 390, 3090 Overijse
- Names & denominations
- APOTHEEK TENNSTEDT-LEVIE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 31 August 1984
- Peppol
- Active · Active since 24 Nov 2023
- Activities · NACE
Apotheken
Apothekers
Detailhandel in cosmetica en toiletartikelen
Detailhandel in cosmetica en toiletartikelen in gespecialiseerde winkels
Detailhandel in drogisterijartikelen en onderhoudsproducten in gespecialiseerde winkels
Detailhandel in drogisterijartikelen en onderhoudsproducten
Gespecialiseerde detailhandel in drogisterijartikelen en onderhoudsproducten